Wuxi Taxus Pharmaceutical

The organization was founded in February 2006. It is a pharmaceutical firm associated with the yew health sector of the Hongdou Group. This sector is a key emerging industry for the Hongdou Group's structural optimization and transformation. The company specializes in the research, development, production, and sales of taxanes, particularly anti-tumor raw materials and preparations. Currently, it has established an industrial chain for yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection, and other anti-tumor drug preparations.